Novo Nordisk Foundation, Wellcome, and the Gates Foundation Join Forces to Accelerate Global Health Equity and Impact

Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation announced a groundbreaking partnership at the Global Science Summit in Denmark, pledging $300 million to support global health R&D. Focused on accessibility and affordability in low- and middle-income countries (LMICs), the initiative targets climate change health impacts, infectious diseases like antimicrobial resistance (AMR), and the intricate nexus of nutrition, immunity, and disease.

By integrating expertise across sectors, the collaboration aims to pioneer innovative solutions, from climate data to vaccine development, to safeguard vulnerable populations worldwide. The partnership signals a concerted effort to bridge disparate fields and confront pressing global health challenges head-on. Read more from their press release here.